Private Equity
The national provider of specialty pharmacy and home infusion services expects to field first-round bids in mid-September.
3 min read · 26 August 2021
The firm invested in Canada's Matcon in its debut control deal, riding the growing demand for infrastructure services.
2 min read · 26 August 2021
The Chicago PE shop is buying the provider of complex respiratory and infusion-therapy services via an initiative with former Onco360 CEO Paul Jardina, with a deal poised to close imminently.
3 min read · 25 August 2021
The Chicago firm adds to an already busy year of healthcare dealmaking with an $800m-plus deal for the global provider of biological specimens and value-added services.
3 min read · 24 August 2021
As the Boston firm hunts for new healthcare investment opportunities in pharma services, medical device manufacturing and tech-enabled services, it continues to actively recruit for another senior position on the technology side.
2 min read · 24 August 2021
Mize is Syncron's first add-on since a growth investment by Summit in 2018.
2 min read · 18 August 2021
Lazard is advising the company on its sale process, which is expected to command interest from telecommunication providers and private equity firms.
2 min read · 18 August 2021
The PE firm bought a roughly 5% stake in the travel company, according to sources.
2 min read · 17 August 2021
As JAB Investors reportedly readies to take National Veterinary Associates public, it writes yet another large check to grow its specialty vet business.
3 min read · 16 August 2021
The PE firm embarks on a buy and build strategy with Spectra A&D, an aerospace and defense holding company.
2 min read · 16 August 2021
